CDC logo
Safer Healthier People
CDC Home CDC Search CDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

Search for NIOSH Publications: NIOSHTIC-2

NIOSHTIC-2 Search Results

      Advanced Search  |  Help  |  About  |  Feedback 
Terms: glutaraldehyde
5 - 5 of 60 Bibliographic entries
Save All   |   Save Page
View Saved    |    Download
Select check boxes to automatically save entries, or use 'save all' or 'save page' links above.
Back to Results
Inhalation of ortho-phthalaldehyde vapor causes systemic sensitization and allergic inflammation in the lymph nodes, nasal mucosa, and lung of mice.
Authors
Johnson-VJ; Wang-W; Fluharty-K; Yucesoy-B; Reynolds-JS
Source
Toxicologist 2011 Mar; 120(Suppl 2):20
Link
http://www.toxicology.org/ms/AMpubs.asp 
NIOSHTIC No.
20038440 
Abstract
Ortho-Phthalaldehyde (OPA) is increasingly being substituted for glutaraldehyde as a high-level disinfectant for sensitive medical devices. However, toxicological data on OPA safety is lacking. Safety concerns for glutaraldehyde include acute nasal toxicity and sensory irritation as well as sensitization leading to occupational rhinitis and asthma. Since OPA is a dialdehyde like glutaraldehyde and functions as a disinfectant due to its high reactivity for biological macromolecules, it is reasonable to expect similar respiratory hazards. Several case reports have been published supporting this hypothesis showing development of respiratory hypersensitivity reactions in healthcare workers and patients exposed to OPA. The purpose of this study was to determine if OPA is a respiratory sensitizer using a murine model. Mice were exposed via inhalation to OPA vapor 4 hrs/day for 3 days; rested for 11 days; challenged with OPA vapor 4 hrs/day for 3 days and then sacrificed 24 hrs after the final exposure. Lungs, nasal mucosa, head-draining lymph nodes (LN) and serum were collected and processed for cytokine gene expression and flow cytometry. OPA-specific antibodies were detected in the serum of exposed mice. OPA inhalation induced a dose dependent increase in LN IL-4 expression and B-cell proliferation. Importantly, there was a concomitant increase in IgE+ B-cells. Strong Th2 cytokine expression in the nasal mucosa increased with OPA dose whereas the inverse was observed for IFN(y) expression, a cytokine expression pattern commonly observed in response to respiratory allergens. Th2 cytokine expression was also increased in the lung although to a lesser extent. These data demonstrate that OPA inhalation induces a predominant Th2 cytokine response in the respiratory tract and draining LN. Importantly, OPA inhalation induced isotype switching to IgE in the draining LN supporting the development of an allergic immune response. Overall, this study suggests that inhalation of OPA vapor in mice can induce respiratory allergy.
Keywords
Allergic-reactions; Biological-effects; Cell-biology; Cellular-reactions; Chemical-cleaning; Chemical-hypersensitivity; Chemical-reactions; Cytotoxic-effects; Dose-response; Exposure-levels; Health-care-personnel; Inhalation-studies; Laboratory-animals; Laboratory-testing; Lung-cells; Lung-disorders; Lung-irritants; Medical-facilities; Microscopic-analysis; Physiological-effects; Quantitative-analysis; Respiratory-hypersensitivity; Respiratory-irritants; Respiratory-system-disorders; Statistical-analysis; Toxic-dose; Toxic-effects; Toxicology; Toxic-vapors
CAS No.
643-79-8
Publication Date
20110301
Document Type
Abstract
Fiscal Year
2011
NTIS Accession No.
NTIS Price
ISSN
1096-6080
NIOSH Division
HELD
Source Name
The Toxicologist. Society of Toxicology 50th Annual Meeting and ToxExpo, Washington, DC, March 6-10, 2011
State
WV; DC
Page 5 of 60

File Formats Help:

Adobe PDF file
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?double arrows.